Abstract: A method for assessing hearing abilities of a human person having two cars, the method comprising: —providing two audio signals (S1, S2) to two respective car speakers (15, 16) at a person's corresponding cars; —measuring at least one value of at least one parameter (x15, y15, z15, x16, y16, z16) representative of the person's head position, adapting at least one of the two audio signals (S1, S2) based on the at least one measured value ((x15, y15, z15, x16, y16, z16), and repeating the measuring and adapting often enough for the sounds provided to the person to correspond to their actual head position; —detecting that the person has found their best perception of the two sounds; —calculating from the person's head position corresponding to the best perception an overall sensitivity value, a differential sensitivity value and/or a value of a latency shift of the person.

Abstract: Disclosed herein are compounds according to Formula I; a pharmaceutical composition including, consisting essentially of, or consisting of: a pharmaceutically acceptable compound of Formula I and a pharmaceutically acceptable carrier, diluent, or excipient; the use of compounds of Formula I in the preparation of a medicament; and a method including administering a pharmaceutical compositions comprising the compound of Formula I to a patient. The compounds, compositions, use, and methods are directed to the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders.

Abstract: Disclosed herein are compounds according to Formula I; a pharmaceutical composition including, consisting essentially of, or consisting of: a pharmaceutically acceptable compound of Formula I and a pharmaceutically acceptable carrier, diluent, or excipient; the use of compounds of Formula I in the preparation of a medicament; and a method including administering a pharmaceutical compositions comprising the compound of Formula I to a patient. The compounds, compositions, use, and methods are directed to the treatment of neurological, psychiatric disorders which are characterised by a fundamental disruption of social behaviour, and substance use disorders.